About Us

Reinventing humanity’s relationship with microbes.

Concerto Biosciences Announces Appointment of Dr. Stewart Campbell to Board of Directors

Dermatology Times • 11 20 2024

Concerto Biosciences Doses First Participant in Phase 1 Trial of ENS-002, a Microbiome-Based Therapy for Atopic Dermatitis

MSN • 11 20 2024

Concerto doses first subject in Phase I trial of ENS-002 for atopic dermatitis

From Concerto • 11 19 2024

Concerto Biosciences Announces First Participant Dosed with Live Biotherapeutic ENS-002 in Phase 1 Trial for Atopic Dermatitis

Bio.News • 7 11 2024

NIH Innovation Zone 2024: Concerto Biosciences illuminates collaboration of microbes

From Concerto • 6 26 2024

Concerto Biosciences Receives FDA Investigational New Drug Clearance for Live Biotherapeutic Product to Treat Atopic Dermatitis

See All News

Our Mission

We create safe, effective microbial products for our world.

First came antibiotics. Then came genetic engineering. Concerto is catalyzing a third wave of microbial technologies to capture what microbes do best: Protect the health of our bodies, our food, and our planet. Accessing these microbial ecology-inspired products requires rigorous discovery science, a strong collaborative culture, and an unyielding commitment to improvement.

Our Values

Grow by experimenting

Work rigorously

Listen intently

Act with compassion

Permission to Play

Concerto embraces a foundational set of additional values that we believe ought to be evident in any startup.

Harness microbial ecology with Concerto to develop new, transformative products.

Partner With Us

Microbes, like humans, are stronger together than they ever could be alone.

Visit Us

750 Main Street 
Cambridge, MA 02139

concerto-biosciences @concertobio info@concertobio.com